Forward Ventures
HOME COMPANY TEAM STRATEGY CRITERIA FINANCES PORTFOLIO PORTFOLIO NEWS FORWARD NEWS SUBMIT YOUR PLAN CONTACT

Thank you for your interest in Forward Ventures. If you wish to submit a brief business plan or executive summary, please send the information to:


Forward Ventures
Attention: Nancy Hong
9393 Towne Centre Drive
Suite 200
San Diego, CA 92121


Fax: (858) 452-8799
hong@forwardventures.com


Does your plan fit the criteria? Check Criteria


Please note: Forward Ventures focuses exclusively
on life science and healthcare related business.


Remember: Your business plan or executive summary
should contain the following information:

» The Business
» The Market
» Technology and Products
» Management and Board of Directors
» Financials: Current and Projected
» Proceeds: Use and Amount Raised

Disclaimer: Forward Ventures has no obligation to protect or preserve the information contained within a submitted business plan. In absence of a definitive agreement executed by Forward Ventures, no legal obligation of any kind or nature is created by the submission of a business plan. Accordingly, please act carefully in deciding to include any sensitive or confidential information in your plan as Forward Ventures will have no obligation to maintain the confidentiality of the information and will be under no restriction with respect to such information.

6/15/2008
Funding gap threatens San Diego, U.S. biotech prominence
San Diego Union Utribune
more
3/21/2007
EISAI To Aquire Morphotek
Morphotek Press Release
more
3/5/2007
Lilly announces acquisition of Hypnion
Hypnion Press Release
more
1/11/2007
Dr. Ivor Royston talked about his career and his transition from research scientist to entrepreneur and then venture capitalist on I’m There for You Baby: The Entrepreneur’s Guide to the Galaxy.
The Entrepreneur’s Guide to the Galaxy
more
7/25/2007
Merck & Co., Inc. to Acquire NovaCardia, Inc., to Boost Clinical Pipline of Cardiovascular Drug Candidates
NovaCardia Press Release
more
7/12/2007
TargeGen, Inc. Closes $40M Series “D” Financing Round
Targegen Press Release
more
5/29/2007
Avalon Pharmaceuticals Closes $20 Million in Private Placement of Common Stock and Warrants to Institutional Investors
Avalon Press Release
more
5/9/2007
TargeGen Receives 2007 James D. Watson Helix Award
TargeGen Press Release
more
5/9/2007
Avalon Pharmaceuticals Reports First Quarter 2007 Results
Avalon Press Release
more

9393 Towne Center Drive | Suite 200 | San Diego, CA 92121